newsfilter
← Latest News
GlobeNewswire·

Galecto Reports Third Quarter Operating and Financial Results

BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the development of novel treatments for fibrosis and